Funded Tech Companies
Visiox Pharma
Operating out of Tarrytown, Visiox Pharma has funding from private investors.
Company Overview
Company Name
Visiox Pharma
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
303 S Broadway 125
Tarrytown, NY 10591
USA
Tarrytown, NY 10591
USA
Phone
Website
Email Address
Company Background Information
Overview
Visiox is a privately funded biopharmaceutical company focused on the development and commercialization of ophthalmic therapeutic candidates to address highly prevalent diseases in need of new treatment options. Each day is an opportunity for us to disrupt and revolutionize the current market to maximize patient and physician satisfaction. As an agile business partner, we will achieve this through a high level of collaboration with all eye care professionals. Our first asset, PDP-716, is a once-daily brimonidine for ocular hypertension and open angle glaucoma. Our second asset, SDN-037, is a twice daily topical difluprednate for post-surgical inflammation and pain. Each product utilizes a unique, proprietary, extended release technology that is patent protected through at least 2036.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
8/3/2022
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Ryan Bleeks
Co-Founder
Zachary Rome
Company Investors
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a leading supplier of venture capital funding data.
Additional Resources for Entrepreneurs